More work is needed to reduce the use of “potentially toxic” steroids in patients with rheumatoid arthritis, research from the British Society for Rheumatology (BSR) Annual Conference 2020 concludes. An analysis of UK prescribing trends over the past two decades found that despite an increase in the use of disease-modifying anti-rheumatic drugs (DMARDs), overall prescribing ...
Steroid use in RA remains steady despite DMARDs
By Emma Wilkinson
28 Apr 2020